Can you provide the average price target for BIOMX INC stock?
8 analysts have analysed PHGE and the average price target is 168.3 USD. This implies a price increase of 21214.59% is expected in the next year compared to the current price of 0.7896.
BIOMX INC (PHGE) Forecast, Price Target & Analyst Ratings
NYSEARCA:PHGE • US09090D5095
Current stock price
0.7896 USD
-0.06 (-7.11%)
At close:
0.7855 USD
0 (-0.52%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOMX INC (PHGE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$168.30
Upside
+ 21,214.59%
From current price of $0.79 to mean target of $168.30, Based on 8 analyst forecasts
Low
$26.26
Median
$168.30
High
$319.20
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for PHGE. The average price target is 168.3 USD. This implies a price increase of 21214.59% is expected in the next year compared to the current price of 0.7896.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PHGE was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PHGE.
In the previous month the buy percentage consensus was at a similar level.
PHGE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-28 | Laidlaw & Co. | Initiate | Buy |
| 2024-05-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2022-11-10 | Chardan Capital | Maintains | Buy |
| 2022-05-24 | Chardan Capital | Maintains | Buy |
| 2022-05-12 | Ladenburg Thalmann | Maintains | Buy |
| 2021-11-16 | Chardan Capital | Maintains | Buy |
| 2021-10-19 | Chardan Capital | Maintains | Buy |
| 2021-10-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-15 | Ladenburg Thalmann | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 193.08% | N/A 334.91% | N/A 127.54% | N/A 54.06% | N/A 42.22% | ||||||||
| EBITDA YoY % growth | N/A | -80K | -28.08M -35,000.00% | -32.89M -17.13% | -24.7M 24.90% | -24.477M 0.90% | -34.636M -41.50% | -27.998M 19.17% | N/A -39.53% | N/A -18.02% | N/A 11.95% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -400K | -30.26M -7,465.00% | -35.46M -17.18% | -27.22M 23.24% | -25.348M 6.88% | -36.439M -43.75% | -30.92M 15.15% | N/A -25.93% | N/A -17.07% | N/A 0.50% | N/A -73.31% | N/A 65.33% | N/A 328.73% | N/A 139.29% | N/A 70.87% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -13.00 -537.25% | -13.90 -6.92% | -9.40 32.37% | -5.30 43.62% | N/A -834.26% | -23.56 52.42% | N/A 47.03% | N/A -6.09% | N/A 3.35% | N/A -151.41% | N/A 66.27% | N/A 291.07% | N/A 139.25% | N/A 67.97% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
13.36%
EPS Next 5 Year
9.01%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-7.04%
EBIT Next 5 Year
N/A
BIOMX INC / PHGE Forecast FAQ
When does BIOMX INC (PHGE) report earnings?
BIOMX INC (PHGE) will report earnings on 2026-05-13.